Human Metabolome TechnologiesHuman Metabolome Technologies, Inc.6090東証スタンダードサービス業FY ending Jun 2026, consolidated, J-GAAP

What does Human Metabolome Technologies do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

Operating cash flow
¥208.6M
Capex
¥83.4M
of revenue 5.9%
Free cash flow
¥125.2M
Returned to shareholders
¥274.5M
of net income: 137%
Dividend per share
¥18
Payout ratio (reported)
51.1%

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income¥200.4M
Operating cash flow¥208.6M
Cash conversion (operating CF ÷ operating income)
99.4%
Cash vs. profit gap
¥8.2M(純利益の 4.1%)
Shareholder returns
of net income 137.0% · of FCF 219.2%
Shareholder payments — dividends
of net income 42.4% · of FCF 67.9%
CapEx intensity (capex ÷ revenue)
5.9%
Investing CF relative to operating CF
40.0%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Five-year trend

Operating cash flow¥208.6M
FY ending Jun 2022: ¥324M¥324MFY ending Jun 2023: ¥285M¥285MFY ending Jun 2024: ¥236.8M¥236.8MFY ending Jun 2025: ¥373.5M¥373.5MFY ending Jun 2026: ¥208.6M¥208.6MFY22FY23FY24FY25FY26
Free cash flow¥125.2M
FY ending Jun 2022: ¥177.9M¥177.9MFY ending Jun 2023: ¥168.1M¥168.1MFY ending Jun 2024: ¥202.7M¥202.7MFY ending Jun 2025: ¥224.8M¥224.8MFY ending Jun 2026: ¥125.2M¥125.2MFY22FY23FY24FY25FY26
Net income¥200.4M
FY ending Jun 2022: ¥267.8M¥267.8MFY ending Jun 2023: ¥285.8M¥285.8MFY ending Jun 2024: ¥243.2M¥243.2MFY ending Jun 2025: ¥256.4M¥256.4MFY ending Jun 2026: ¥200.4M¥200.4MFY22FY23FY24FY25FY26

How to read this

  • Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
  • Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
  • Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第23期(2025/07/01-2026/06/30)

    ID S100Z2EI2026-09-17Open
  • EDINET (FSA Japan)

    有価証券報告書-第22期(2024/07/01-2025/06/30)

    ID S100WPSX2025-09-22Open
  • EDINET (FSA Japan)

    有価証券報告書-第21期(2023/07/01-2024/06/30)

    ID S100UE9D2024-09-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第20期(2022/07/01-2023/06/30)

    ID S100RW1Z2023-09-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第19期(令和3年7月1日-令和4年6月30日)

    ID S100P8152022-09-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第18期(令和2年7月1日-令和3年6月30日)

    ID S100MHKD2021-09-27Open

Extracted from XBRL: 48 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.